Skip to main content

Table 2 Univariate and multivariate analysis for PFS and OS in all patients with OMC

From: Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature

 

Progression-free survival

Overall survival

 

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Variables

HR (95 % CI)

p-value

HR (95 % CI)

p-value

HR (95 % CI)

p-value

HR (95 % CI)

p-value

Age (years)

 ≥51 vs. <51

0.51 (0.17–1.42)

0.20

  

0.71 (0.20–2.35)

0.57

  

FIGO stage

 I vs. II, III, IV

0.11 (0.04–0.32)

< 0.01

0.12 (0.02–0.61)

0.01

0.06 (0.01–0.22)

< 0.01

0.09 (0.01–0.84)

0.04

Residual tumor at PDS

 Optimal vs. Suboptimal

0.17 (0.06–0.50)

< 0.01

0.95 (0.20–3.55)

0.94

0.09 (0.02–0.29)

< 0.01

0.37 (0.05–1.68)

0.21

Invasive pattern

 Infiltrative invasion vs. Expansile invasion

8.69 (2.37–55.86)

< 0.01

9.01 (2.28–61.41)

< 0.01

12.52 (2.37-230.59)

< 0.01

17.56 (2.58-393.24)

< 0.01

  1. Abbreviations: PFS Progression-free survival, OS Overall survival, OMC ovarian mucinous carcinoma, HR hazard ratio, CI confidence interval, PDS primary debulking surgery